$121 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 11 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 8.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REAL | THE REALREAL | $65,921,000 | +82.5% | 5,154,080 | 0.0% | 54.67% | +43.2% | |
GKOS | Sell | GLAUKOS CORP | $24,833,000 | -20.6% | 646,364 | -36.2% | 20.59% | -37.7% |
AGTC | APPLIED GENETIC TECHNOL CORP | $8,066,000 | +68.9% | 1,455,904 | 0.0% | 6.69% | +32.6% | |
EIGR | EIGER BIOPHARMACEUTICALS INC | $7,343,000 | +41.2% | 764,918 | 0.0% | 6.09% | +10.8% | |
CDTX | CIDARA THERAPEUTICS INC | $5,007,000 | +48.8% | 1,356,813 | 0.0% | 4.15% | +16.8% | |
KALV | KALVISTA PHARMACEUTICALS INC | $4,704,000 | +58.2% | 388,766 | 0.0% | 3.90% | +24.2% | |
VERO | VENUS CONCEPT INC | $2,299,000 | -1.7% | 658,657 | 0.0% | 1.91% | -22.8% | |
STIM | NEURONETICS INC | $1,989,000 | +2.1% | 1,030,689 | 0.0% | 1.65% | -19.9% | |
OBALON THERAPEUTICS INC | $268,000 | -2.2% | 380,224 | 0.0% | 0.22% | -23.2% | ||
XENE | XENON PHARMACEUTICALS INC | $104,000 | +10.6% | 8,293 | 0.0% | 0.09% | -13.1% | |
DARE | DARE BIOSCIENCE INC | $50,000 | +16.3% | 50,368 | 0.0% | 0.04% | -8.9% | |
MGNX | Exit | MACROGENICS INC | $0 | – | -1,074,316 | -100.0% | -6.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
THE REALREAL | 18 | Q3 2023 | 62.6% |
KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
MACROGENICS INC | 14 | Q1 2020 | 19.2% |
PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-27 |
13F-HR | 2023-10-20 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-25 |
13F-HR | 2022-08-02 |
13F-HR | 2022-04-13 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.